What This Site Is
An independent editorial project auditing the BPC-157 peer-reviewed literature. Not a clinic. Not a vendor.
BPC-157 across four regulatory dimensions as of 2025: FDA prohibits compounding (Category 2), WADA prohibits use (S0), DEA does not schedule, EMA has not reviewed.
Publisher Statement
BPC-157 Legit is an independent editorial project that publishes summaries of the peer-reviewed research literature on Body Protection Compound 157 (BPC-157). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The domain name modifier — 'legit' — is an editorial position: this site exists to ask and answer the question of what legitimacy means in the context of BPC-157, specifically as that word applies to the scientific evidence record and the regulatory record. It is not a claim that we certify products, provide clinical services, or operate any pharmaceutical or healthcare function. We are a publisher. Our medium is editorial text. Our sources are indexed peer-reviewed journals, regulatory agency documents, and published systematic and narrative reviews.
The editorial team behind this site does not include physicians, pharmacists, pharmacologists, or any other licensed healthcare professionals. Content is produced by research writers who apply editorial standards to the published scientific record. Nothing on this site constitutes medical, legal, or regulatory advice.
Editorial Methodology
Every factual claim on this site is sourced to a specific publication in the references list. We apply the following standards:
Source hierarchy
Primary sources — original peer-reviewed research papers — are preferred over reviews. Systematic reviews and narrative reviews published in indexed journals are cited when they synthesize multiple primary studies. Secondary or tertiary sources (news articles, vendor websites, community forums) are not cited.
Regulatory documents
FDA Category 2 classification, WADA Prohibited List entries, and DEA scheduling status are cited from official agency publications and regulatory documents, not from secondary reporting.
Quantitative claims
Every dose value, half-life figure, bioavailability percentage, study count, or other quantitative statement is sourced to a specific publication with a citation marker. No figures are estimated or interpolated.
Framing
All findings from animal studies are described as findings from animal studies, with the species and model named. Human clinical data are described as such, with sample sizes noted. We do not extrapolate from animal data to human outcomes. We do not project from preclinical findings to clinical recommendations.
Controversy
Where the research record contains documented limitations — including the concentration of BPC-157 research in a single research group, the absence of published Phase II trial data, the absence of independent replication, and the absence of human pharmacokinetic data — we report those limitations explicitly rather than omitting them from the summary.
What This Site Is Not
This site does not sell BPC-157 or any other compound. It is not affiliated with any vendor, supplier, compounding pharmacy, or commercial enterprise that sells peptide products. It does not accept affiliate commissions from any peptide supplier.
This site does not provide personalized research guidance. The research context presented on this site represents what appears in the published literature; it does not constitute advice about specific research protocols, dosing parameters for any particular use case, or sourcing recommendations.
The word 'doctor' does not appear in the domain name of this site. The word 'legit' is an editorial framing — a question posed about the research and regulatory record — not a claim about the site's services, personnel, or credentials. No claim of medical or clinical expertise is made or implied anywhere on this site.
For information about BPC-157's regulatory status, consult the FDA website (fda.gov), the WADA Prohibited List (wada-ama.org), and USADA's substance information (usada.org). For questions about individual health, consult a licensed healthcare provider.